Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: An open label pilot study

Chi Un Pae, David M. Marks, Changsu Han, Prakash S. Masand, Ashwin A. Patkar

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This study evaluated the efficacy of pregabalin augmentation of antidepressant treatment in patients with posttraumatic stress disorder (PTSD). Nine patients meeting Diagnostic and Statistical Manual, fourth edition criteria for PTSD who were on stable doses of antidepressants were treated open label with flexibly dosed pregabalin for 6 weeks. All patients were assessed with the Short PTSD Rating Interview, Montgomery-Asberg Depression Rating Scale, Patient Global Impressionseverity, Visual Analog Scale-pain, and Sheehan Disability Scale at baseline and weeks 2, 4, and 6. Significant reductions were observed in all effectiveness measures from week 4 to the end of the study. In particular, the numerical improvement of the Visual Analog Scale-pain score was most robust (- 53.4%, P=0.007). Pregabalin augmentation was effective and well tolerated during the study. Our findings warrant adequately powered, placebocontrolled clinical trials to confirm the usefulness of pregabalin augmentation of antidepressants in patients with PTSD.

Original languageEnglish
Pages (from-to)29-33
Number of pages5
JournalInternational Clinical Psychopharmacology
Volume24
Issue number1
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Post-Traumatic Stress Disorders
Antidepressive Agents
Accidents
Pain Measurement
Pregabalin
Clinical Trials
Interviews
Depression
Therapeutics

Keywords

  • Antidepressant
  • Augmentation
  • Posttraumatic stress disorder
  • Pregabalin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder : An open label pilot study. / Pae, Chi Un; Marks, David M.; Han, Changsu; Masand, Prakash S.; Patkar, Ashwin A.

In: International Clinical Psychopharmacology, Vol. 24, No. 1, 01.01.2009, p. 29-33.

Research output: Contribution to journalArticle

@article{7b0371cc20384c98b64181c23713c60e,
title = "Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: An open label pilot study",
abstract = "This study evaluated the efficacy of pregabalin augmentation of antidepressant treatment in patients with posttraumatic stress disorder (PTSD). Nine patients meeting Diagnostic and Statistical Manual, fourth edition criteria for PTSD who were on stable doses of antidepressants were treated open label with flexibly dosed pregabalin for 6 weeks. All patients were assessed with the Short PTSD Rating Interview, Montgomery-Asberg Depression Rating Scale, Patient Global Impressionseverity, Visual Analog Scale-pain, and Sheehan Disability Scale at baseline and weeks 2, 4, and 6. Significant reductions were observed in all effectiveness measures from week 4 to the end of the study. In particular, the numerical improvement of the Visual Analog Scale-pain score was most robust (- 53.4{\%}, P=0.007). Pregabalin augmentation was effective and well tolerated during the study. Our findings warrant adequately powered, placebocontrolled clinical trials to confirm the usefulness of pregabalin augmentation of antidepressants in patients with PTSD.",
keywords = "Antidepressant, Augmentation, Posttraumatic stress disorder, Pregabalin",
author = "Pae, {Chi Un} and Marks, {David M.} and Changsu Han and Masand, {Prakash S.} and Patkar, {Ashwin A.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1097/YIC.0b013e32831feea9",
language = "English",
volume = "24",
pages = "29--33",
journal = "International Clinical Psychopharmacology",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder

T2 - An open label pilot study

AU - Pae, Chi Un

AU - Marks, David M.

AU - Han, Changsu

AU - Masand, Prakash S.

AU - Patkar, Ashwin A.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - This study evaluated the efficacy of pregabalin augmentation of antidepressant treatment in patients with posttraumatic stress disorder (PTSD). Nine patients meeting Diagnostic and Statistical Manual, fourth edition criteria for PTSD who were on stable doses of antidepressants were treated open label with flexibly dosed pregabalin for 6 weeks. All patients were assessed with the Short PTSD Rating Interview, Montgomery-Asberg Depression Rating Scale, Patient Global Impressionseverity, Visual Analog Scale-pain, and Sheehan Disability Scale at baseline and weeks 2, 4, and 6. Significant reductions were observed in all effectiveness measures from week 4 to the end of the study. In particular, the numerical improvement of the Visual Analog Scale-pain score was most robust (- 53.4%, P=0.007). Pregabalin augmentation was effective and well tolerated during the study. Our findings warrant adequately powered, placebocontrolled clinical trials to confirm the usefulness of pregabalin augmentation of antidepressants in patients with PTSD.

AB - This study evaluated the efficacy of pregabalin augmentation of antidepressant treatment in patients with posttraumatic stress disorder (PTSD). Nine patients meeting Diagnostic and Statistical Manual, fourth edition criteria for PTSD who were on stable doses of antidepressants were treated open label with flexibly dosed pregabalin for 6 weeks. All patients were assessed with the Short PTSD Rating Interview, Montgomery-Asberg Depression Rating Scale, Patient Global Impressionseverity, Visual Analog Scale-pain, and Sheehan Disability Scale at baseline and weeks 2, 4, and 6. Significant reductions were observed in all effectiveness measures from week 4 to the end of the study. In particular, the numerical improvement of the Visual Analog Scale-pain score was most robust (- 53.4%, P=0.007). Pregabalin augmentation was effective and well tolerated during the study. Our findings warrant adequately powered, placebocontrolled clinical trials to confirm the usefulness of pregabalin augmentation of antidepressants in patients with PTSD.

KW - Antidepressant

KW - Augmentation

KW - Posttraumatic stress disorder

KW - Pregabalin

UR - http://www.scopus.com/inward/record.url?scp=58349094358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349094358&partnerID=8YFLogxK

U2 - 10.1097/YIC.0b013e32831feea9

DO - 10.1097/YIC.0b013e32831feea9

M3 - Article

C2 - 19060720

AN - SCOPUS:58349094358

VL - 24

SP - 29

EP - 33

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

SN - 0268-1315

IS - 1

ER -